Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Examining Roles of DDX56 in Flavivirus Infections
EF 2013-14
Résumé
Viruses are small, often pathogenic agents that infect a wide variety of hosts including humans. Many are able to cause serious disease in their host, and transmission within a susceptible population can lead to regional and in some cases, global outbreaks. Thus, viruses are of particular significance to the health of the global population and measures should be taken to further understand the mechanisms behind viral infections and disease.
Viruses are not free-living entities meaning that living cells are needed for their ability to replicate. A typical viral lifecycle begins when the particle binds to and enters a host cell. Following replication of the viral genome and production of new proteins, the virus' genetic material is packaged into daughter virions that are released from the cell. Due to their limited coding capacity, viruses are highly reliant on host cell molecules for replication and translation. As such, identification of host molecules that are essential for virus lifecycles may facilitate development of new targets for antiviral therapy.
My research is focused on West Nile Virus (WNV) and related flaviviruses that cause encephalitis in humans and other hosts. These viruses are able to infect the central nervous system and spinal cord resulting in inflammation and long-term brain damage or death. Globally, encephalitic viruses infect hundreds of millions of people each year, a situation that is exacerbated by the lack of adequate prevention and treatment methods. To this end, our lab has identified a host molecule, DDX56, which is important for production of infectious West Nile particles. In non-infected cells DDX56 is found within the nucleus, a specialized region that harbors the genetic material of the host cell. During WNV infection, DDX56 moves out of the nucleus into the cytoplasm where it is thought to function in the production of infectious daughter particles. Because DDX56 is not required for growth of human cells in vitro, it may be a suitable target for antiviral therapy.
My goal to further investigate the mechanism by which DDX56 functions in assembly of infectious WNV particles and also if it is required for production of other encephalitic viruses. I hypothesize that DDX56 is involved in packaging virus genetic material into daughter virions. I will employ a variety of complementary approaches to investigate exactly how DDX56 functions in viral infections. In doing so, I believe that my work could form the basis for development of antiviral therapies used to treat viral encephalitis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311727
Name
Reid Colleen R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining Roles of DDX56 in Flavivirus Infections
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antiviral Target; Host Cell Proteins; Microscopy; Proteomics; Virology
Abstract
Viruses are small, often pathogenic agents that infect a wide variety of hosts including humans. Many are able to cause serious disease in their host, and transmission within a susceptible population can lead to regional and in some cases, global outbreaks. Thus, viruses are of particular significance to the health of the global population and measures should be taken to further understand the mechanisms behind viral infections and disease.
Viruses are not free-living entities meaning that living cells are needed for their ability to replicate. A typical viral lifecycle begins when the particle binds to and enters a host cell. Following replication of the viral genome and production of new proteins, the virus' genetic material is packaged into daughter virions that are released from the cell. Due to their limited coding capacity, viruses are highly reliant on host cell molecules for replication and translation. As such, identification of host molecules that are essential for virus lifecycles may facilitate development of new targets for antiviral therapy.
My research is focused on West Nile Virus (WNV) and related flaviviruses that cause encephalitis in humans and other hosts. These viruses are able to infect the central nervous system and spinal cord resulting in inflammation and long-term brain damage or death. Globally, encephalitic viruses infect hundreds of millions of people each year, a situation that is exacerbated by the lack of adequate prevention and treatment methods. To this end, our lab has identified a host molecule, DDX56, which is important for production of infectious West Nile particles. In non-infected cells DDX56 is found within the nucleus, a specialized region that harbors the genetic material of the host cell. During WNV infection, DDX56 moves out of the nucleus into the cytoplasm where it is thought to function in the production of infectious daughter particles. Because DDX56 is not required for growth of human cells in vitro, it may be a suitable target for antiviral therapy.
My goal to further investigate the mechanism by which DDX56 functions in assembly of infectious WNV particles and also if it is required for production of other encephalitic viruses. I hypothesize that DDX56 is involved in packaging virus genetic material into daughter virions. I will employ a variety of complementary approaches to investigate exactly how DDX56 functions in viral infections. In doing so, I believe that my work could form the basis for development of antiviral therapies used to treat viral encephalitis.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Reid, Colleen R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~